RANITIDINE SAFETY STUDY
Monitor presence of potentially carcinogenic chemical in Ranitidine: DCGI to drug controllersThe DCGI has directed state and UT drug controllers to monitor levels of the potentially carcinogenic NDMA in Ranitidine, an antacid. This ...
Ranitidine ban deferred despite cancer concernsDespite concerns about cancer-causing agents in Ranitidine and an expert panel's recommendation to suspend it, India's drug advisory body h...
- Load More